Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase I/II, First-In-Human Trial of SRA141 for the Treatment of Advanced Colorectal Cancer

Next Previous
Trial Profile

A Phase I/II, First-In-Human Trial of SRA141 for the Treatment of Advanced Colorectal Cancer

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 06 Mar 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs AS 0141 (Primary)
  • Indications Colorectal cancer
  • Focus Adverse reactions; First in man
  • Sponsors Sierra Oncology

    • Most Recent Events

    • 28 Feb 2019 According to a Sierra Oncology media release, the company is currently evaluating the optimal timing to commence this trial.
    • 13 Nov 2018 According to a Sierra Oncology media release, the Investigational New Drug Application (IND) process for SRA141 with the FDA has been completed and the IND application for SRA141 has been accepted by the U.S. FDA.
    • 10 Aug 2018 According to a Sierra Oncology media release, Upon dosing of the first patient in the first Phase 1 clinical trial of SRA141, a milestone payment of $4.0 million will be due to Carna Biosciences, Inc. (Carna), the licensor of this asset.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top